Fantastic ALS signed “Anne,” three pages, 5.5 x 8.5, March 8, 1977. Letter to journalist Alden Whitman of the New York Times, in part: “I remember at some point disagreeing with you—& others—about calling Charles ‘a leader.’ I don’t think he was or wanted to be ‘a leader.’ Leaders (like T. E. Lawrence, F.D.R. or Martin Luther King […]) want certain things: followers, influence, popularity, a movement behind them, political position etc. Charles really never wanted or went after any of these things. He had causes he advanced—but usually alone. He was much more of a Crusader than a leader...The other story I remember telling you was of his first contacts with Carrel, who was impressed by Charles’ scientific and technical curiousity [sic] and inventiveness. I was always very amused by hearing from an outside source of Carrel telling his two old friends...‘My friends, this world will hear from this young man someday!’ (This being a year or so after Charles’ Trans Atlantic flight.) This story illustrates the point I was making in my last letter that Charles was continually surprising people by breaking in a new role. It also illustrates what water-tight compartments scientists—and all of us—tend to live in.” In fine condition. Rife with excellent content about her husband’s inadvertent leadership and insatiable curiosity, this letter also mentions one of Lindbergh’s most frequently overlooked achievements—his collaboration with Nobel Prize–winning surgeon Alexis Carrel to invent the first perfusion pump, opening the door to future heart surgeries and organ transplants. Pre-certified PSA/DNA.
This item is Pre-Certified by PSA/DNA
Buy a third-party letter of authenticity for
$50.00
*This item has been pre-certified by a trusted third-party authentication service, and by placing a bid on this item, you agree to accept the opinion of this authentication service. If you wish to have an opinion rendered by a different authenticator of your choosing, you must do so prior to your placing of any bid. RR Auction is not responsible for differing opinions submitted 30 days after the date of the sale.
